UNSPSC 51392610: Phenylpropanolamine maleate

This classification denotes an adrenergic agonist with the molecular formula C9H13NO.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 86ILV507ZN. Most nations, for tariff and trade purposes, schedule phenylpropanolamine maleate under HS 29394900. As of Q4 2014, PHENYLPROPANOLAMINE MALEATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@@H]([C@@H](C1CCCCC1)O)N.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51392610 Phenylpropanolamine maleate is a Commodity code covering pharmaceutical products, though the recent state and local procurement activity under this code reflects a significant mismatch between the code's nominal scope and actual buying patterns. The single recent solicitation tagged to this code — Seminole County, Florida's IFB for Naloxone and Drug Deactivation Systems — involves opioid-overdose reversal medications and harm-reduction equipment rather than phenylpropanolamine, a decongestant no longer commonly procured by state and local health agencies. The code shows minimal recent activity in state and local procurement, with no evidence of sustained demand for the pharmaceutical product it nominally describes.

Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The procurement requires electronic bid submission, inclusion of all shipping and delivery costs, drug-free workplace certification, and E-Verify compliance, with an initial two-year contract term and one-year renewal option. The solicitation reflects FEMA funding, introducing federal compliance overlays including the Clean Air Act and Federal Water Pollution Control Act, and includes a three-month probationary termination clause. Given the code's apparent misclassification in this opportunity and the absence of additional recent phenylpropanolamine procurements, pursuit under this code is not recommended; state and local buyers interested in pharmaceutical procurement should monitor codes aligned with opioid-response initiatives or general pharmaceutical supply contracts.